text_1: JMJD6 slows the hydroxylation of C-terminal lysine
text_2: Our results reveal a novel posttranslational modification for p53 and support the pursuit of JMJD6 as a potential biomarker for colon cancer aggressiveness and a potential target for colon cancer intervention.